Alpine Partners VI »

Dianthus Therapeutics shares owned by Alpine Partners VI

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Alpine Partners VI from 13F filings

Historical chart of Alpine Partners VI investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Alpine Partners VI consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Alpine Partners VI

Quarter filed Position value Share count Share price at filing
2024-06-30 $605k 23k 25.88

More positions owned by Alpine Partners VI

Immunovant (IMVT)
Cornerstone Strategic Value (CLM)
Microstrategy Cl A New (MSTR)
Robinhood Mkts Com Cl A (HOOD)
Cornerstone Total Rtrn Fd In (CRF)
Archer Aviation Com Cl A (ACHR)
Microsoft Corporation (MSFT)
Live Nation Entertainment In Note 2.000% 2/1
Rivian Automotive Note 4.625% 3/1
Vishay Intertechnology Note 2.250% 6/1
Veeco Instrs Inc Del Note 2.875% 6/0
Alphabet Cap Stk Cl A (GOOGL)
Snap Note 0.125% 3/0
Burlington Stores Note 2.250% 4/1
Ncl Corp Note 5.375% 8/0

View all positions for Alpine Partners VI

Top funds holding Dianthus Therapeutics

Bain Capital Life Sciences Investors
Avidity Partners Management
Fairmount Funds Management
RA Capital Management
Octagon Capital Advisors
VR Adviser
BlackRock
BlackRock
Vanguard Group
5AM Venture Management
Henderson Group
Braidwell
Geode Capital Management
Point72 Asset Management
State Street Corporation

View all funds holding Dianthus Therapeutics